EpiPrEP Pitt Pilot Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Are you a HIV-negative man who has sex with other men? Are you planning on going away on vacation soon? If so, you may be eligible to participate in a study to help investigators test the feasibility and acceptability of short-term PrEP. PrEP is taking medications typically used to treat HIV to help prevent HIV. Compensation provided.
IRB: STUDY19050227
- Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among Gay, Bisexual and other Men who Have Sex with Men (MSM): Pitt PilotMEET THE RESEARCHER

Ken Ho
Ken S. Ho, MD, MPH, is Medical Director at Pitt Men’s Study at the University of Pittsburgh. Dr. Ho’s primary research focuses on biomedical strategies for HIV prevention.